AL096816.1

ENSG00000280135, also known as AL096816.1, is annotated as a novel transcript in the human genome and does not have functional or therapeutic target annotation[1][5]. There is no published evidence that it codes for a biologically active protein or participates in known molecular pathways associated with disease or pharmacology. It is not considered a receptor, enzyme, transporter, transcription factor, or similar molecular entity relevant to drug targeting. This entry refers to a genomically annotated sequence with no clear evidence of protein-coding function or clinical relevance[1][5]. It is not recognized in public annotations as a validated drug target, nor is it associated with any disease role or pharmacological agent. This is a typical case of a genomic entry that would be considered “not a therapeutic target,” and appears to be a placeholder or predicted transcript with no demonstrated function. If you are seeking a validated druggable target, this entry should not be pursued further as there is insufficient information to classify it as such.

Other names

ENSG00000280135